A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : suPAR

Search Conditions:
Search Keyword : suPAR
Search Method : Exact match.
Research Area:

Abbreviation: suPAR
Appearance Frequency: 736 time(s)
Long forms: 16

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
soluble urokinase plasminogen activator receptor
(595 times)
(52 times)
CRP (84 times)
AUC (34 times)
FSGS (32 times)
1995 Enhancement of the enzymatic activity of single-chain urokinase plasminogen activator by soluble urokinase receptor.
soluble uPAR
(60 times)
(14 times)
uPAR (35 times)
uPA (17 times)
GPI (6 times)
1996 Single-chain urokinase-type plasminogen activator bound to its receptor is relatively resistant to plasminogen activator inhibitor type 1.
soluble urokinase receptor
(47 times)
(11 times)
FSGS (23 times)
eGFR (4 times)
CKD (3 times)
1999 Soluble urokinase receptor released from human carcinoma cells: a plasma parameter for xenograft tumour studies.
soluble uPA receptor
(9 times)
General Surgery
(2 times)
uPA (9 times)
PAI-1 (3 times)
CI (2 times)
1996 Interaction of single-chain urokinase with its receptor induces the appearance and disappearance of binding epitopes within the resultant complex for other cell surface proteins.
soluble form of uPAR
(8 times)
(3 times)
uPA (4 times)
uPAR (3 times)
ATF (1 time)
1996 Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect.
soluble forms of the urokinase receptor
(3 times)
(1 time)
ELISA (2 times)
HIV (1 time)
MDD (1 time)
2000 Increased levels of urokinase receptor in plasma of head and neck squamous cell carcinoma patients.
soluble fraction of the plasminogen activator receptor
(2 times)
(1 time)
ELISA (2 times)
CI (1 time)
EDTA (1 time)
2001 Prognostic importance of the soluble plasminogen activator receptor, suPAR, in plasma from rectal cancer patients.
soluble urokinase activator receptor
(2 times)
(1 time)
cfmtDNA (1 time)
G-CSF (1 time)
nDNA (1 time)
2005 Soluble urokinase activator receptor (suPAR) in stem cell mobilization.
soluble, recombinant uPAR
(2 times)
(1 time)
uPAR (2 times)
HK (1 time)
HUVEC (1 time)
1997 Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor.
10  surface receptor
(2 times)
(1 time)
APOL1 (1 time)
CHF (1 time)
CoQ10 (1 time)
2019 Longitudinally Measured Fibrinolysis Factors are Strong Predictors of Clinical Outcome in Patients with Chronic Heart Failure: The Bio-SHiFT Study.
11  soluble extracellular form of uPAR
(1 time)
(1 time)
CK1 (1 time)
HK (1 time)
uPAR (1 time)
2011 Interaction of high-molecular-weight kininogen with endothelial cell binding proteins suPAR, gC1qR and cytokeratin 1 determined by surface plasmon resonance (BiaCore).
12  soluble receptor of urokinase
(1 time)
(1 time)
FSGS (1 time)
HDs (1 time)
IA (1 time)
2013 Protein A immunoadsorption cannot significantly remove the soluble receptor of urokinase from sera of patients with recurrent focal segmental glomerulosclerosis.
13  soluble receptor of urokinase plasminogen activator
(1 time)
BMI (1 time)
CI (1 time)
CV (1 time)
2018 Soluble Urokinase Plasminogen Activator Receptor (suPAR) and All-Cause and Cardiovascular Mortality in Diverse Hemodialysis Patients.
14  soluble uPAR in serum
(1 time)
Clinical Laboratory Techniques
(1 time)
uPAR (1 time)
2012 Evaluating the value of uPAR of serum and tissue on patients with cervical cancer.
15  soluble urokinase receptor of plasminogen activator
(1 time)
Veterinary Medicine
(1 time)
HMGB-1 (1 time)
ICAM-1 (1 time)
PAI-1 (1 time)
2017 Blood markers of fibrinolysis and endothelial activation in canine babesiosis.
16  study was designed to measure plasma
(1 time)
(1 time)
CKD (1 time)
suPARs (1 time)
2019 Clinical value of soluble urokinase type plasminogen activator receptors in chronic kidney disease.